Skip to content

Effect of an interactive SMS system in improving the reporting of adverse drug reactions among people living with HIV in Tanzania and Uganda: a randomized controlled trial: The REMIND ADR TRIAL

Effect of an interactive SMS system in improving the reporting of adverse drug reactions among people living with HIV in Tanzania and Uganda: a randomized controlled trial: The REMIND ADR TRIAL

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
PACTR
Registry ID
PACTR202503561138751
Enrollment
228
Registered
2025-03-03
Start date
2023-08-01
Completion date
Unknown
Last updated
2026-09-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

HIV/AIDS

Interventions

Standard of care

Sponsors

Kilimanjaro Clinical Research Institute
Lead Sponsor
Uganda Virus Research Institute
Collaborator

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: ? Age between 18 and 65 ? confirmed and documented HIV infection ? Being on ART treatment for at least 3 months ? Able to read and understand SMS ? Able to understand and be willing to sign the informed consent document ? Able to read and write a text message ? Have a mobile phone

Exclusion criteria

Exclusion criteria: ? Critically ill patients. ? Participating in other clinical trials.

Design outcomes

Primary

MeasureTime frame
The main outcome measure will be the proportion of participants reporting ADR in the two arms.

Secondary

MeasureTime frame
The other outcome measures will be the frequencies of the different ADR profiles reported

Countries

Tanzania, Uganda, United Republic of Tanzania

Contacts

Public ContactKenedy;Benjamin Ngowi;Watyaba

Researcher at KCRI;Reseacher

k.ngowi@kcri.ac.tz;bwatyaba@uvri.go.ug+255758048649;+256777601103

Outcome results

None listed

Source: PACTR (via WHO ICTRP) · Data processed: Sep 19, 2026